Clinical trials: Chric Phase MPN
Myelofibrosis, MPN - Accelerated or Blast Phase
Oral Tetrahydrouridine-Decitabine in Patients With Advanced Myeloproliferative Neoplasms
This is a phase II, multicenter, open-label study evaluating the feasibility, safety, and efficacy of oral tetrahydrouridine-decitabine (THU-decitabine) in patients with advanced myeloproliferative neoplasms (MPN).
- Conditions
- Myelofibrosis, MPN - Accelerated or Blast Phase, Chric Phase MPN
- Trial name
- MPN-RC 127 (NCT07872709)
- Testing
- Oral THU-decitabine
- Where
- United States
- Volunteers
- 20 people
- Sponsor
- John Mascarenhas